Search Within

Alan Loh Ho

  1. "Neuroradiology Service"
Formats
  1. Meeting Abstract (23)
  2. Journal Article (21)
  3. Editorial (1)
Groups
  1. Department of Medicine (45)
  2. Head and Neck Service (45)
  3. Neuroradiology Service (45)
  4. Radiology, Department of (45)
  5. Solid Tumor Oncology Division (45)
  6. Department of Pathology and Laboratory Medicine (34)

More Groups

People
  1. David Pfister (41)
  2. Eric Sherman (41)
  3. Sofia Haque (40)
  4. Lara Dunn (24)
  5. Nora Katabi (19)
  6. Shrujal Baxi (18)

More People

Years
  1. 2024 (3)
  2. 2023 (3)
  3. 2022 (4)
  4. 2021 (3)
  5. 2020 (5)
  6. 2019 (4)

More Years

Publications
  1. Journal of Clinical Oncology (25)
  2. Annals of Oncology (3)
  3. Cancer (3)
  4. European Journal of Nuclear Medicine and Molecular Imaging (2)
  5. International Journal of Radiation Oncology, Biology, Physics (2)
  6. Cancer Chemotherapy and Pharmacology (1)

More Publications

Publishers
  1. American Society of Clinical Oncology (25)
  2. Oxford University Press (5)
  3. Springer (4)
  4. Wiley Blackwell (3)
  5. Elsevier Inc. (2)
  6. John Wiley & Sons (1)

More Publishers

Results (45)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Enhancing radioiodine (RAI) incorporation into BRAF(V600E)-mutant, RAI-refractory thyroid cancers with the BRAF inhibitor vemurafenib: A pilot study
    Meeting Abstract

    Dunn, L.; Sherman, E. J.; Baxi, S. S.; Grewal, R. K.; Pentlow, K. S.; Haque, S.; Tuttle, R. M.; Sabra, M.; Fish, S.; Boucai, L.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • A phase II study of axitinib (AG-013736) in patients with incurable adenoid cystic carcinoma
    Journal Article

    Ho, A. L.; Dunn, L.; Sherman, E. J.; Fury, M. G.; Baxi, S. S.; Chandramohan, R.; Dogan, S.; Morris, L. G. T.; Cullen, G. D.; Haque, S.; more...
    Annals of Oncology (2016)

    Fulltext@MSK | Save
  • Assessment of second-line VEGF-inhibitor therapy in radioiodine-refractory (RAIR) differentiated thyroid cancer (DTC)
    Meeting Abstract

    Dunn, L.; Ho, A. L.; Haque, S.; Fury, M. G.; Baxi, S. S.; Cullen, G.; Pfister, D. G.; Sherman, E. J.
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Phase II study of axitinib in patients with progressive, recurrent/metastatic adenoid cystic carcinoma
    Meeting Abstract

    Ho, A. L.; Sherman, E. J.; Fury, M. G.; Baxi, S. S.; Haque, S.; Sima, C. S.; Antonescu, C. R.; Katabi, N.; Pfister, D. G.
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • A phase II trial of temsirolimus plus low-dose weekly carboplatin and paclitaxel for recurrent/metastatic HNSCC
    Meeting Abstract

    Fury, M. G.; Xiao, H.; Baxi, S. S.; Sherman, E. J.; Smith-Marrone, S.; Ho, A. L.; Sima, C. S.; Nwankwo, O. G.; Haque, S.; Katabi, N.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • A phase II study of pralatrexate with vitamin B12 and folic acid supplementation for previously treated recurrent and/or metastatic head and neck squamous cell cancer
    Journal Article

    Ho, A. L.; Lipson, B. L.; Sherman, E. J.; Xiao, H.; Fury, M. G.; Apollo, A.; Seetharamu, N.; Sima, C. S.; Haque, S.; Lyo, J. K.; more...
    Investigational New Drugs (2014)

    Fulltext@MSK | Save
  • Phase II study of everolimus and sorafenib for the treatment of metastatic thyroid cancer
    Meeting Abstract

    Sherman, E. J.; Ho, A. L.; Fury, M. G.; Baxi, S. S.; Haque, S.; Lipson, B. L.; Kurz, S.; Fagin, J. A.; Pfister, D. G.
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • A phase 1 study of everolimus + weekly cisplatin + intensity modulated radiation therapy in head-and-neck cancer
    Journal Article

    Fury, M. G.; Lee, N. Y.; Sherman, E.; Ho, A. L.; Rao, S.; Heguy, A.; Shen, R.; Korte, S.; Lisa, D.; Ganly, I.; more...
    International Journal of Radiation Oncology, Biology, Physics (2013)

    Fulltext@MSK | Save
  • A phase 1 study of everolimus plus docetaxel plus cisplatin as induction chemotherapy for patients with locally and/or regionally advanced head and neck cancer
    Journal Article

    Fury, M. G.; Sherman, E.; Ho, A. L.; Xiao, H.; Tsai, F.; Nwankwo, O.; Sima, C.; Heguy, A.; Katabi, N.; Haque, S.; more...
    Cancer (2013)

    Fulltext@MSK | Save
  • Selumetinib-enhanced radioiodine uptake in advanced thyroid cancer
    Journal Article

    Ho, A. L.; Grewal, R. K.; Leboeuf, R.; Sherman, E. J.; Pfister, D. G.; Deandreis, D.; Pentlow, K. S.; Zanzonico, P. B.; Haque, S.; Gavane, S.; more...
    New England Journal of Medicine (2013)

    Fulltext@MSK | Save